Helper T cells (CD3+/CD4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients

The microenvironment in the bone marrow — including lymphocytes — is part of the pathophysiology of multiple myeloma (MM). High dose chemotherapy followed by autologous stem cell transplantation is standard of care for younger patients. Aim: To determine the influence of reinfused lymphocyte subsets...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2008
Автори: Schmidmaier, R., Oversohl, N., Schnabel, B., Straka, C., Emmerich, B.
Формат: Стаття
Мова:English
Опубліковано: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2008
Назва видання:Experimental Oncology
Теми:
Онлайн доступ:http://dspace.nbuv.gov.ua/handle/123456789/139909
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:Helper T cells (CD3+/CD4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients / R. Schmidmaier, N. Oversohl, B. Schnabel, C. Straka, B. Emmerich // Experimental Oncology. — 2008. — Т. 30, № 3. — С. 240–243. — Бібліогр.: 17 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id irk-123456789-139909
record_format dspace
fulltext
spelling irk-123456789-1399092018-06-22T03:03:56Z Helper T cells (CD3+/CD4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients Schmidmaier, R. Oversohl, N. Schnabel, B. Straka, C. Emmerich, B. Uncategorized The microenvironment in the bone marrow — including lymphocytes — is part of the pathophysiology of multiple myeloma (MM). High dose chemotherapy followed by autologous stem cell transplantation is standard of care for younger patients. Aim: To determine the influence of reinfused lymphocyte subsets on event free survival (EFS) and overall survival (OS). Methods: In peripheral blood (PB) and aphaeresis products (AP) of 41 MM patients lymphocyte subsets were determined by flow cytometry and were correlated with clinical outcome. Results: PB lymphocyte subsets did not influence EFS or OS. Residual plasma cells in the AP were not correlated with poor outcome, whereas a high percentage of B cells (CD19+) showed a trend towards reduced EFS (P = 0.051). A high amount of CD4 cells and an increased CD4/CD8 ratio were significantly associated with prolonged EFS. In contrast, high percentage of HLA-DR positive lymphocytes showed negative impact on EFS and OS (P = 0.03 and 0.02, respectively). Conclusion: Obtained data suggest the non-activated (HLA-DR negative) helper CD4+ T cells in the AP to be tumour protective. Микроокружение в костном мозге, включая лимфоциты, оказывает влияние на патофизиологию множественной миеломы (MM). Высокодозовая химиотерапия, за которой следует аутологическая трансплантация стволовых клеток, является стандартным подходом при лечении более молодых пациентов. Цель: изучить влияние введенных субпопуляций лимфоцитов на безрецидивную выживаемость (EFS) и общую выживаемость больных c ММ. Методы: методом проточной цитофлуориметрии в периферической крови (PB) и продуктах афереза (АР) пациентов с ММ ( n = 41) изучали субпопуляции лимфоцитов и возможную корреляцию с исходом болезни. Результаты: субпопуляции лимфоцитов РB не влияли на EFS или OS. Остаточные клетки плазмы в АР не коррелировали с плохим прогнозом, в тоже время при высоком содержании В-клеток (CD19+) отмечали тенденцию к снижению EFS (P = 0,051). Высокое содержание CD4-клеток и увеличение соотношения CD4/CD8 были достоверно ассоциированы с повышением EFS. В отличие от этого, высокий процент HLADR-положительных лимфоцитов имел отрицательное влияние на EFS и OS (P = 0,03 и 0,02 соответственно). Выводы: полученные данные позволяют предположить, что неактивированные (HLA-DR-отрицательные) хелперные CD4+ T-клетки в AP могут обладать антиопухолевыми свойствами. 2008 Article Helper T cells (CD3+/CD4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients / R. Schmidmaier, N. Oversohl, B. Schnabel, C. Straka, B. Emmerich // Experimental Oncology. — 2008. — Т. 30, № 3. — С. 240–243. — Бібліогр.: 17 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/139909 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
language English
topic Uncategorized
Uncategorized
spellingShingle Uncategorized
Uncategorized
Schmidmaier, R.
Oversohl, N.
Schnabel, B.
Straka, C.
Emmerich, B.
Helper T cells (CD3+/CD4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients
Experimental Oncology
description The microenvironment in the bone marrow — including lymphocytes — is part of the pathophysiology of multiple myeloma (MM). High dose chemotherapy followed by autologous stem cell transplantation is standard of care for younger patients. Aim: To determine the influence of reinfused lymphocyte subsets on event free survival (EFS) and overall survival (OS). Methods: In peripheral blood (PB) and aphaeresis products (AP) of 41 MM patients lymphocyte subsets were determined by flow cytometry and were correlated with clinical outcome. Results: PB lymphocyte subsets did not influence EFS or OS. Residual plasma cells in the AP were not correlated with poor outcome, whereas a high percentage of B cells (CD19+) showed a trend towards reduced EFS (P = 0.051). A high amount of CD4 cells and an increased CD4/CD8 ratio were significantly associated with prolonged EFS. In contrast, high percentage of HLA-DR positive lymphocytes showed negative impact on EFS and OS (P = 0.03 and 0.02, respectively). Conclusion: Obtained data suggest the non-activated (HLA-DR negative) helper CD4+ T cells in the AP to be tumour protective.
format Article
author Schmidmaier, R.
Oversohl, N.
Schnabel, B.
Straka, C.
Emmerich, B.
author_facet Schmidmaier, R.
Oversohl, N.
Schnabel, B.
Straka, C.
Emmerich, B.
author_sort Schmidmaier, R.
title Helper T cells (CD3+/CD4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients
title_short Helper T cells (CD3+/CD4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients
title_full Helper T cells (CD3+/CD4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients
title_fullStr Helper T cells (CD3+/CD4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients
title_full_unstemmed Helper T cells (CD3+/CD4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients
title_sort helper t cells (cd3+/cd4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
publishDate 2008
topic_facet Uncategorized
url http://dspace.nbuv.gov.ua/handle/123456789/139909
citation_txt Helper T cells (CD3+/CD4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients / R. Schmidmaier, N. Oversohl, B. Schnabel, C. Straka, B. Emmerich // Experimental Oncology. — 2008. — Т. 30, № 3. — С. 240–243. — Бібліогр.: 17 назв. — англ.
series Experimental Oncology
work_keys_str_mv AT schmidmaierr helpertcellscd3cd4withintheautologousperipheralbloodstemcellgraftpositivelycorrelatewitheventfreesurvivalofmultiplemyelomapatients
AT oversohln helpertcellscd3cd4withintheautologousperipheralbloodstemcellgraftpositivelycorrelatewitheventfreesurvivalofmultiplemyelomapatients
AT schnabelb helpertcellscd3cd4withintheautologousperipheralbloodstemcellgraftpositivelycorrelatewitheventfreesurvivalofmultiplemyelomapatients
AT strakac helpertcellscd3cd4withintheautologousperipheralbloodstemcellgraftpositivelycorrelatewitheventfreesurvivalofmultiplemyelomapatients
AT emmerichb helpertcellscd3cd4withintheautologousperipheralbloodstemcellgraftpositivelycorrelatewitheventfreesurvivalofmultiplemyelomapatients
first_indexed 2025-07-10T09:21:49Z
last_indexed 2025-07-10T09:21:49Z
_version_ 1837251228682158080